Urology & Nephrology News, Treatment Studies | Renal, Urology …
网页By John Schieszer, MA. A proposed 2025 Physician Fee Schedule conversion factor of $32.36 represents a 2.8% decrease from 2024.
News Archive - Renal and Urology News
网页5 天之前 · This is the first study to evaluate kidney outcomes after sacubitril/valsartan vs ACEi/ARB treatment among patients with hypertension-associated thrombotic microangiopathy.
Jardiance Approved for Adults With Chronic Kidney Disease
网页September 25, 2023. The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR), end ...
Prostatic Artery Embolization Offers Lasting Benefit for BPH
网页2 天之前 · October 7, 2024. PAE is safe and effective for men with lower urinary tract symptoms or acute urinary retention. (HealthDay News) — For men with benign prostatic hyperplasia (BPH), prostatic ...
Study: Ibuprofen Found Safest NSAID for the Kidney
网页2021年5月10日 · Ibuprofen was the safest NSAID, conferring a significant 12% increased risk of incident eGFR less than 60, 32% increased risk of an eGFR decline of 30% or greater, and 34% increased risk of the ...
Proton Therapy, IMRT for Prostate Cancer Offer Similar Quality of …
网页2 天之前 · Investigators randomly assigned 226 patients with low- to intermediate-risk prostate cancer to proton beam therapy (PBT) and 224 patients to intensity-modulated radiation therapy (IMRT). Median ...
Water Vapor Therapy for BPH Safe, Effective in Large Real-World …
网页May 14, 2022. Real-world data confirm that RezÅ«m therapy, a minimally invasive procedure that uses water vapor to ablate prostate tissue, is safe and effective for treating benign prostatic ...
Farxiga Approved for Patients With CKD at Risk of Progression
网页May 4, 2021. The Food and Drug Administration (FDA) has approved Farxiga ® (dapagliflozin) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end stage kidney ...
Kidney Function Declines More Slowly With SGLT2 Inhibitor
网页2022年11月7日 · Mean eGFR declined more slowly per year with empagliflozin vs DPP4i treatment: -1.33 vs -2.26 mL/min/1.73 m 2 per year, Dr Mosenzon reported on behalf of his team. The eGFR slope became gentler ...
Survival Outcomes in Gleason 9-10 PCa Similar With Radiation, …
网页2016年8月2日 · The 10-year rates of overall survival were 79.9%, 84.7%, and 90.3%, respectively. The 5-year and 10-year distant metastasis-free survival rates were significantly higher with EBRT plus BT (94.6% ...